He should resign.
FDA commissioner says criticism for misrepresenting convalescent plasma stats is warranted
BY NATHANIEL WEIXEL - 08/24/20
The head of the Food and Drug Administration (FDA) on Monday said criticism for his praise of convalescent plasma treatment was warranted, but denied the decision to authorize the emergency use of the treatment for COVID-19 patients was politically motivated.
"I have been criticized for remarks I made Sunday night about the benefits of convalescent plasma. The criticism is entirely justified. What I should have said better is that the data show a relative risk reduction not an absolute risk reduction," Stephen Hahn said in a lengthy Twitter post.
more:
http://thehill.com/policy/healthcare/513485-fda-chief-says-criticism-for-misrepresenting-convalescent-plasma-stats-is
DO SOMETHING!
| 